Systematic review, meta-analysis, and meta-regression: Successful second-line treatment for Helicobacter pylori

Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis

(2017) James K.Y. Hooi et al.   GASTROENTEROLOGY

Helicobacter pylori infection and antibiotic resistance: a WHO high priority?

(2017) Bich N. Dang et al.   Nature Reviews Gastroenterology & Hepatology

Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy

(2016) Zhiqiang Song et al.   DIGESTIVE AND LIVER DISEASE

IV Conferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori

(2016) Javier P. Gisbert et al.   Gastroenterologia y Hepatologia

The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults

(2016) Carlo A. Fallone et al.   GASTROENTEROLOGY

Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report

(2016) P Malfertheiner et al.   GUT

Helicobacter pylorisecond-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments

(2015) J. P. Gisbert et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment forHelicobacter pyloriinfection

(2015) Sheila López-Góngora et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Fourteen-day optimized levofloxacin-based therapy versus classical quadruple therapy for Helicobacter pylori treatment failures: a randomized clinical trial

(2015) Zhijun Cao et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Fourteen- vs seven-day bismuth-based quadruple therapy for second-line Helicobacter pylori eradication

(2015) Jae Jin Hwang   WORLD JOURNAL OF GASTROENTEROLOGY

Comparison of Second-Line Quadruple Therapies with or without Bismuth forHelicobacter pyloriInfection

(2015) Guang-Hong Jheng et al.   Biomed Research International

Tetracycline- and Furazolidone-containing Quadruple Regimen as Rescue Treatment forHelicobacter pyloriInfection: A Single Center Retrospective Study

(2014) Yuemiao Zhang et al.   HELICOBACTER

The Clinical and Bacteriological Factors for Optimal Levofloxacin-Containing Triple Therapy in Second-Line Helicobacter pylori Eradication

(2014) Wei-Chen Tai et al.   PLoS One

Levofloxacin, Metronidazole, and Lansoprazole Triple Therapy Compared to Quadruple Therapy as a Second-Line Treatment ofHelicobacter pyloriInfection in Korea

(2013) Ji Yoon Moon et al.   Gut and Liver

Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pyloriEradication in Taiwan

(2013) Wei-Chen Tai et al.   Gastroenterology Research and Practice

Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report

(2012) Peter Malfertheiner et al.   GUT

The Efficacy of Second-Line Anti-Helicobacter pyloriTherapy Using an Extended 14-Day Levofloxacin/Amoxicillin/Proton-Pump Inhibitor Treatment - A Pilot Study

(2012) Seng-Kee Chuah et al.   HELICOBACTER

Comparison of Lafutidine and Rabeprazole in 7-day Second-line Amoxicillin- and Metronidazole-Containing Triple Therapy for Helicobacter pylori: A Pilot Study

(2012) Takahiko Kudo et al.   HELICOBACTER

Comparison of 10 day bismuth quadruple therapy with high-dose metronidazole or levofloxacin for second-line Helicobacter pylori therapy: a randomized controlled trial

(2012) C.-H. Kuo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Levofloxacin/amoxicillin-based schemesvsquadruple therapy forHelicobacter pylorieradication in second-line

(2012) Simona Di Caro   WORLD JOURNAL OF GASTROENTEROLOGY

Moxifloxacin-Containing Triple Therapy versus Bismuth-Containing Quadruple Therapy for Second-Line Treatment of Helicobacter pylori Infection: A Meta-Analysis

(2011) Cheng Wu et al.   HELICOBACTER

Efficacy of 2-Week, Second-Line Helicobacter pylori Eradication Therapy Using Rabeprazole, Amoxicillin, and Metronidazole for the Japanese Population

(2011) Kazutoshi Hori et al.   HELICOBACTER

Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: a multicentre clinical trial

(2011) J.-M. Liou et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

A new look at anti-Helicobacter pylori therapy

(2011) Seng-Kee Chuah   WORLD JOURNAL OF GASTROENTEROLOGY

Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice

(2010) Stefano Pontone et al.   DIGESTIVE AND LIVER DISEASE

A New Second-Line Sequential Regimen for Helicobacter pylori Eradication Based on Levofloxacin: A Pilot Study

(2010) C. Krystallis et al.   DIGESTIVE DISEASES AND SCIENCES

Helicobacter pylori treatment in the era of increasing antibiotic resistance

(2010) D. Y. Graham et al.   GUT

Bismuth-Containing Quadruple Therapy as Second-Line Treatment forHelicobacter pyloriInfection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate in Korea

(2010) Byoung Hwan Lee et al.   HELICOBACTER

Helicobacter pyloriInfection

(2010) Kenneth E.L. McColl   NEW ENGLAND JOURNAL OF MEDICINE

Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis

(2010) Yuqin Li et al.   WIENER KLINISCHE WOCHENSCHRIFT

Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylorieradication

(2009) Jaime N Eisig et al.   BMC GASTROENTEROLOGY

Impact of Quadruple Regimen of Clarithromycin Added to Metronidazole-Containing Triple Therapy AgainstHelicobacter pyloriInfection Following Clarithromycin-Containing Triple-Therapy Failure

(2009) Nobue Ueki et al.   HELICOBACTER

Evaluation of Three Different Proton Pump Inhibitors With Amoxicillin and Metronidazole in Retreatment for Helicobacter pylori Infection

(2009) Kazunari Murakami et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Quadruple therapy with ecabet sodium, omeprazole, amoxicillin and metronidazole is effective for eradication of Helicobacter pylori after failure of first-line therapy (KDOG0201 Study)

(2009) W. Koizumi et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication

(2008) S. Di Caro et al.   DIGESTIVE AND LIVER DISEASE

Relative potency of proton-pump inhibitors—comparison of effects on intragastric pH

(2008) Julia Kirchheiner et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Second-Line Rescue Therapy With Levofloxacin After H. pylori Treatment Failure: A Spanish Multicenter Study of 300 Patients

(2007) Javier P Gisbert et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY